Supplementary Figure from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
作者
Martin H. Voss,Arun Azad,Aaron R. Hansen,Jhanelle E. Gray,Sarah J. Welsh,Xuyang Song,Michael Kuziora,Lina Meinecke,Jorge Blando,Ikbel Achour,Yi Wang,Farzana L. Walcott,Sjoukje F. Oosting
Supplementary Figure from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
无极微光
Criminology34
GingerF
OK
cdercder
Nole
cnspower
科研甜菜
zz
Copyright
老胡
王雪
wueeee
3G就是牛
七月不远
sagitar
潇洒的惋清
不潮薯饼
arniu2008
皖公网安备34019202002308
